Literature DB >> 2719552

Partial deletion of the human host range gene in the attenuated vaccinia virus MVA.

W Altenburger1, C P Süter, J Altenburger.   

Abstract

The genome of a strongly attenuated vaccinia virus strain, MVA, was investigated by Southern blot and sequence analyses. Three major deletions, relative to the WR strain, were localized in MVA DNA. The deletions occurred near both ends of the viral genome and one of them affected a 55 K as well as the 32 K human host range gene. Although more than two thirds of the host range gene were eliminated from the MVA, the virus could still multiply in certain human cells.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2719552     DOI: 10.1007/BF01311113

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  32 in total

1.  The purification fo four strains of poxvirus.

Authors:  W K JOKLIK
Journal:  Virology       Date:  1962-09       Impact factor: 3.616

2.  Excess of interfering over infectious particles in herpes simplex virus passaged at high m.o.i. and their effect on single-cell survival.

Authors:  C H Schröder; G Urbaczka
Journal:  J Gen Virol       Date:  1978-12       Impact factor: 3.891

3.  Mapping the genomic location of the gene encoding alpha-amanitin resistance in vaccinia virus mutants.

Authors:  E C Villarreal; D E Hruby
Journal:  J Virol       Date:  1986-01       Impact factor: 5.103

4.  Localization and sequence of a vaccinia virus gene required for multiplication in human cells.

Authors:  S Gillard; D Spehner; R Drillien; A Kirn
Journal:  Proc Natl Acad Sci U S A       Date:  1986-08       Impact factor: 11.205

5.  [MVA vaccination against smallpox: clinical tests with an attenuated live vaccinia virus strain (MVA) (author's transl)].

Authors:  H Stickl; V Hochstein-Mintzel; A Mayr; H C Huber; H Schäfer; A Holzner
Journal:  Dtsch Med Wochenschr       Date:  1974-11-22       Impact factor: 0.628

6.  Recombinant vaccinia virus LC16m0 or LC16m8 that expresses hepatitis B surface antigen while preserving the attenuation of the parental virus strain.

Authors:  M Morita; K Suzuki; A Yasuda; A Kojima; M Sugimoto; K Watanabe; H Kobayashi; K Kajima; S Hashizume
Journal:  Vaccine       Date:  1987-03       Impact factor: 3.641

7.  Decreased virulence of recombinant vaccinia virus expression vectors is associated with a thymidine kinase-negative phenotype.

Authors:  R M Buller; G L Smith; K Cremer; A L Notkins; B Moss
Journal:  Nature       Date:  1985 Oct 31-Nov 6       Impact factor: 49.962

8.  Comparative studies of several vaccinia virus strains by intrathalamic inoculation into cynomolgus monkeys.

Authors:  M Morita; Y Aoyama; M Arita; H Amona; H Yoshizawa; S Hashizume; T Komatsu; I Tagaya
Journal:  Arch Virol       Date:  1977       Impact factor: 2.574

9.  Vaccinia virus: a selectable eukaryotic cloning and expression vector.

Authors:  M Mackett; G L Smith; B Moss
Journal:  Proc Natl Acad Sci U S A       Date:  1982-12       Impact factor: 11.205

10.  One hundred base pairs of 5' flanking sequence of a vaccinia virus late gene are sufficient to temporally regulate late transcription.

Authors:  C Bertholet; R Drillien; R Wittek
Journal:  Proc Natl Acad Sci U S A       Date:  1985-04       Impact factor: 11.205

View more
  14 in total

1.  Identification and characterization of two nonessential regions of the rabbitpox virus genome involved in virulence.

Authors:  D C Bloom; K M Edwards; C Hager; R W Moyer
Journal:  J Virol       Date:  1991-03       Impact factor: 5.103

2.  Evaluation of the thymidine kinase (tk) locus as an insertion site in the highly attenuated vaccinia MVA strain.

Authors:  F Scheiflinger; F G Falkner; F Dorner
Journal:  Arch Virol       Date:  1996       Impact factor: 2.574

3.  Comparative efficacy of recombinant modified vaccinia virus Ankara expressing simian immunodeficiency virus (SIV) Gag-Pol and/or Env in macaques challenged with pathogenic SIV.

Authors:  I Ourmanov; C R Brown; B Moss; M Carroll; L Wyatt; L Pletneva; S Goldstein; D Venzon; V M Hirsch
Journal:  J Virol       Date:  2000-03       Impact factor: 5.103

4.  Biology of attenuated modified vaccinia virus Ankara recombinant vector in mice: virus fate and activation of B- and T-cell immune responses in comparison with the Western Reserve strain and advantages as a vaccine.

Authors:  J C Ramírez; M M Gherardi; M Esteban
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

5.  Differences and similarities in viral life cycle progression and host cell physiology after infection of human dendritic cells with modified vaccinia virus Ankara and vaccinia virus.

Authors:  Ann Chahroudi; David A Garber; Patrick Reeves; Luzheng Liu; Daniel Kalman; Mark B Feinberg
Journal:  J Virol       Date:  2006-09       Impact factor: 5.103

6.  Recombinant vaccinia virus-induced T-cell immunity: quantitation of the response to the virus vector and the foreign epitope.

Authors:  Laurie E Harrington; Robbert van der Most Rv; J Lindsay Whitton; Rafi Ahmed
Journal:  J Virol       Date:  2002-04       Impact factor: 5.103

Review 7.  Multivalent and Multipathogen Viral Vector Vaccines.

Authors:  Katharina B Lauer; Ray Borrow; Thomas J Blanchard
Journal:  Clin Vaccine Immunol       Date:  2017-01-05

8.  Vaccinia virus-mediated inhibition of type I interferon responses is a multifactorial process involving the soluble type I interferon receptor B18 and intracellular components.

Authors:  Zoe Waibler; Martina Anzaghe; Theresa Frenz; Astrid Schwantes; Christopher Pöhlmann; Holger Ludwig; Marcos Palomo-Otero; Antonio Alcamí; Gerd Sutter; Ulrich Kalinke
Journal:  J Virol       Date:  2008-12-10       Impact factor: 5.103

9.  Stable expression of the vaccinia virus K1L gene in rabbit cells complements the host range defect of a vaccinia virus mutant.

Authors:  G Sutter; A Ramsey-Ewing; R Rosales; B Moss
Journal:  J Virol       Date:  1994-07       Impact factor: 5.103

10.  Microarray analysis reveals characteristic changes of host cell gene expression in response to attenuated modified vaccinia virus Ankara infection of human HeLa cells.

Authors:  Susana Guerra; Luis A López-Fernández; Raquel Conde; Alberto Pascual-Montano; Keith Harshman; Mariano Esteban
Journal:  J Virol       Date:  2004-06       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.